Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts.

Schieck A, Schulze A, Gähler C, Müller T, Haberkorn U, Alexandrov A, Urban S, Mier W.

Hepatology. 2013 Jul;58(1):43-53. doi: 10.1002/hep.26211. Epub 2013 May 15.

PMID:
23292963
[PubMed - indexed for MEDLINE]
2.

Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.

Meier A, Mehrle S, Weiss TS, Mier W, Urban S.

Hepatology. 2013 Jul;58(1):31-42. doi: 10.1002/hep.26181. Epub 2013 Mar 14.

PMID:
23213046
[PubMed - indexed for MEDLINE]
3.

Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S.

Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19.

PMID:
24361467
[PubMed - indexed for MEDLINE]
4.

Characterization of a hepatitis B and hepatitis delta virus receptor binding site.

Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnölzer M, Urban S.

Hepatology. 2006 Apr;43(4):750-60.

PMID:
16557545
[PubMed - indexed for MEDLINE]
5.

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

Volz T, Allweiss L, Ben MBarek M, Warlich M, Lohse AW, Pollok JM, Alexandrov A, Urban S, Petersen J, Lütgehetmann M, Dandri M.

J Hepatol. 2013 May;58(5):861-7. doi: 10.1016/j.jhep.2012.12.008. Epub 2012 Dec 13.

PMID:
23246506
[PubMed - indexed for MEDLINE]
6.

Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Schulze A, Schieck A, Ni Y, Mier W, Urban S.

J Virol. 2010 Feb;84(4):1989-2000. doi: 10.1128/JVI.01902-09. Epub 2009 Dec 9.

PMID:
20007265
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition.

Barrera A, Guerra B, Notvall L, Lanford RE.

J Virol. 2005 Aug;79(15):9786-98.

PMID:
16014940
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.

Lütgehetmann M, Mancke LV, Volz T, Helbig M, Allweiss L, Bornscheuer T, Pollok JM, Lohse AW, Petersen J, Urban S, Dandri M.

Hepatology. 2012 Mar;55(3):685-94. doi: 10.1002/hep.24758. Epub 2012 Jan 30.

PMID:
22031488
[PubMed - indexed for MEDLINE]
9.

Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.

Freitas N, Abe K, Cunha C, Menne S, Gudima SO.

J Virol. 2014 Jun;88(11):6255-67. doi: 10.1128/JVI.00346-14. Epub 2014 Mar 19.

PMID:
24648462
[PubMed - indexed for MEDLINE]
10.

Attachment sites and neutralising epitopes of hepatitis B virus.

Glebe D.

Minerva Gastroenterol Dietol. 2006 Mar;52(1):3-21. Review.

PMID:
16554703
[PubMed - indexed for MEDLINE]
11.

Strategies to inhibit entry of HBV and HDV into hepatocytes.

Urban S, Bartenschlager R, Kubitz R, Zoulim F.

Gastroenterology. 2014 Jul;147(1):48-64. doi: 10.1053/j.gastro.2014.04.030. Epub 2014 Apr 25.

PMID:
24768844
[PubMed - in process]
12.

Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes.

Barrera A, Guerra B, Lee H, Lanford RE.

J Virol. 2004 May;78(10):5233-43.

PMID:
15113905
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Role of glycosaminoglycans for binding and infection of hepatitis B virus.

Leistner CM, Gruen-Bernhard S, Glebe D.

Cell Microbiol. 2008 Jan;10(1):122-33.

PMID:
18086046
[PubMed - indexed for MEDLINE]
14.

Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.

Gripon P, Cannie I, Urban S.

J Virol. 2005 Feb;79(3):1613-22.

PMID:
15650187
[PubMed - indexed for MEDLINE]
Free PMC Article
15.
16.

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.

Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S.

J Hepatol. 2014 Apr;60(4):723-31. doi: 10.1016/j.jhep.2013.11.022. Epub 2013 Dec 1.

PMID:
24295872
[PubMed - in process]
17.

Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitor.

Schieck A, Müller T, Schulze A, Haberkorn U, Urban S, Mier W.

Molecules. 2010 Jul 7;15(7):4773-83. doi: 10.3390/molecules15074773.

PMID:
20657392
[PubMed - indexed for MEDLINE]
Free Article
18.

Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes.

De Meyer S, Gong ZJ, Suwandhi W, van Pelt J, Soumillion A, Yap SH.

J Viral Hepat. 1997 May;4(3):145-53. Review.

PMID:
9181523
[PubMed - indexed for MEDLINE]
19.

Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Chai N, Chang HE, Nicolas E, Gudima S, Chang J, Taylor J.

J Virol. 2007 Oct;81(20):10897-904. Epub 2007 Aug 1.

PMID:
17670822
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.

Chisari FV.

Curr Top Microbiol Immunol. 1996;206:149-73. Review.

PMID:
8608715
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk